Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
NeuroMetrix, Inc.
4372
NeuroMetrix, Inc.
Health Care
Technology
Biotechnology
Medical
Medical Devices
NeuroMetrix is a medical device company focused on the diagnosis and treatmentof the neurological complications of diabetes.
Suggest edits
Type
B2c
Founded
1996
Raised
$71.8M
Follow us
Companies in the same industry
Amedica
Imbed Biosciences
Sway Medical
Intezyne Technologies
NanoCellect Biomedical
Procept BioRobotics
Humacyte
Beijing Allcure Medical Technology
Xip
Concure Oncology
Alexa global traffic share
Twitter followers
Overview
Funding
5
Add info
Latest funding
Show all
$3,500,000
Post-IPO equity - 2017
$7,000,000
Post-IPO equity - 2017
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
ZDNet
NeuroMetrix CEO reflects on the art of AI in the art of healing
Robotics
$7,000,000
Post-IPO equity
businesswire
NeuroMetrix Closes $7.0 Million Private Placement of Preferred Stock and Warrants | Business Wire
$26,500,000
Post-IPO equity
MassDevice
NeuroMetrix raises $27m to buy back convertible shares, warrants
$21,000,000
Post-IPO equity
MassDevice
NeuroMetrix jumps on $21m round as Quell pain device hits 1k retail stores
$13,800,000
Post-IPO equity
BioPortfolio
NeuroMetrix Closes $13.8 Million At-The-Market Private Placement
